Here's What You May or May Not Have Missed This Week:
• The FDA launched its first-ever Patient Engagement Advisory Committee, which will offer perspective to the FDA Commissioner on issues related to the regulation of technology and medical devices and their use by patients. The group will use patient input to help identify the most important benefits and risks of technology and better integrate those perspectives into its regulatory process. Source
• The Office of the National Coordinator for Health IT (ONC) released an updated version of its federal HIT strategic plan, which will focus on ensuring that care is more "person-centered." The plan represents the government's goal for improving the health and wellness of individuals through the use of health IT over the next five years and is a shift from the prior plan where EHR adoption by providers was a heavy focus. Source
• Martin Shkreli, the man responsible for increasing the price of the drug Daraprim from $13.50 per tablet to $750 last week, said that he would finally agree to lower the cost of the 62-year-old drug. The overnight increase of the drug sparked outrage from the public and prompted direct calls from lawmakers and even Hillary Clinton to reduce the price. The incident has urged many to call for new measures to control the rising cost of medicines. Source
On The Front Lines:
Apple was the mobile device of choice this week, gaining 0.09 percent from Android among pMD's charge capture physician users. The iPhone 6s hits stores today and in typical release-day tradition, buyers crowded Apple stores to get a hold of the latest and greatest mobile device.
Each Friday, Signor Goat reports the latest from the week in health care alongside the front lines of the iOS-Android wars among pMD's physician charge capture users. Check back next Friday for your dose of our little medical corner of health care news.